The estimated Net Worth of Anthony A Lombardo is at least 2.03 千$ dollars as of 2 February 2018. Anthony Lombardo owns over 32 units of Ayala Pharmaceuticals stock worth over 1,858$ and over the last 7 years Anthony sold ADXS stock worth over 170$.
Anthony has made over 2 trades of the Ayala Pharmaceuticals stock since 2017, according to the Form 4 filled with the SEC. Most recently Anthony sold 32 units of ADXS stock worth 94$ on 2 February 2018.
The largest trade Anthony's ever made was selling 32 units of Ayala Pharmaceuticals stock on 2 February 2018 worth over 94$. On average, Anthony trades about 14 units every 24 days since 2017. As of 2 February 2018 Anthony still owns at least 92,903 units of Ayala Pharmaceuticals stock.
You can see the complete history of Anthony Lombardo stock trades at the bottom of the page.
Anthony's mailing address filed with the SEC is 305 COLLEGE ROAD EAST, , PRINCETON,, NJ, 08540.
Over the last 21 years, insiders at Ayala Pharmaceuticals have traded over 12,060,930$ worth of Ayala Pharmaceuticals stock and bought 7,108,817 units worth 19,940,745$ . The most active insiders traders include Biotech Fund I, L.P.Israel ...、Capital Partners Gp, L.L.C....、Thomas A Moore. On average, Ayala Pharmaceuticals executives and independent directors trade stock every 107 days with the average trade being worth of 12,473$. The most recent stock trade was executed by Biotech Fund I, L.P.Israel ... on 7 February 2024, trading 27,847,159 units of ADXS stock currently worth 11,138,864$.
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Ayala Pharmaceuticals executives and other stock owners filed with the SEC include: